Hyperoxaluria clinical trials at UCSF
2 in progress, 1 open to eligible people
Hyperoxaluria occurs when there is too much oxalate in the body, affecting kidneys. At UCSF, research is being done on DCR-PHXC to check its effectiveness and safety. The trial includes participants with PH1 and serious kidney issues, some requiring dialysis.
DCR-PHXC in Patients With PH1 and ESRD
open to all eligible people
The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.
San Francisco, California and other locations
Long Term Extension Study in Patients With Primary Hyperoxaluria
Sorry, in progress, not accepting new patients
The proposed study is designed to provide patients previously enrolled in Phase 1 and 2 studies of DCR-PHXC and their siblings (<18 years old) long-term access to DCR-PHXC, and to evaluate the long-term safety and efficacy of DCR-PHXC in patients with PH.
San Francisco, California and other locations
Last updated: